Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.12) per share. This is a 97.07 percent increase over losses of $(4.10) per share from the same period last year.
Regulators Probe Morgan Stanley’s Wealth-Management Division: Report
Federal regulators, including the SEC and OCC, reportedly probe Morgan Stanley's wealth division for potential money laundering, focusing on client vetting and financial monitoring. The investigation follows concerns raised by the Federal Reserve last November.
